Cantor Fitzgerald Reiterates Overweight Rating on Cartesian Therapeutics (RNAC)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: RNAC) | Delayed: 6.34 -0.15 (2.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.49 | 52 Week High | $ | |||
| Open | $6.49 | 52 Week Low | $ | |||
| Day High | $6.68 | P/E | N/A | |||
| Day Low | $6.20 | EPS | $ | |||
| Volume | 114,729 | |||||
